Seagen Inc.

Ownership Transactions Reported by 16 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
21823 30 Th Drive Se, Suite, Bothell, WA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Seagen Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Clay B. Siegall President & CEO, Director $153M May 12, 2022
Marc E. Lippman Director $12.3M May 14, 2021
David R. Epstein CEO, Director Dec 14, 2023
Daniel G. Welch Director Dec 14, 2023
Nancy A. Simonian Director Dec 14, 2023
Ted W. Love Director Dec 14, 2023
Charles R. Romp EVP, Commercial U.S. Dec 14, 2023
Roger D. Dansey President, R&D & CMO Dec 14, 2023
Todd E. Simpson Chief Financial Officer Dec 14, 2023
Jean I. Liu Chief Legal Officer Dec 14, 2023
David W. Gryska Director Dec 14, 2023
Alpna Seth Director Dec 14, 2023
John A. Orwin Director Dec 14, 2023
Baker Bros. Advisors Lp Director, Former 10% Owner Dec 14, 2023
Vaughn Himes Chief Technical Officer Dec 14, 2023
Sandra M. Swain Director Dec 14, 2023

Recent Insider Transactions by Companies or Individuals for Seagen Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.